Leadership & Management
Women in Leadership Series – Interview with Leanne Elich

Leadership takes courage and resilience. Health Industry Hub Founder, Rozalina Sarkezians, shares insights from Pharma, MedTech and Biotech’s diverse female leaders on the sometimes complex challenges faced by women on the path to senior leadership.
Leanne Elich’s intriguing background, from a clinical oncologist to the MedTech industry and more recently to a consulting role, makes her the perfect candidate to discuss the following:
- How do you respond to Workplace Gender Equality Agency (WGEA)’s recent data on the gender pay gap in Australia?
- What are key challenges that you have faced over the years as a female leader? How did you find the inspiration to overcome these?
- What is the one key insight about leadership that you wish a mentor had told you about years ago?
- How would you like to see ‘women in leadership’ evolve in the post-COVID era?
Interview
About
As one of Australasia’s successful Medical Technology Business Leaders, Leanne Elich is a passionate Oncology Advocate and Global Healthcare Specialist with over 25 years experience in both clinical and corporate environments with executive leadership.
Leanne began her career immediately after graduating from the University of Sydney working as a medical oncologist at Prince of Wales and Liverpool Hospitals in Sydney.
With a desire to help patients on a larger scale and make a significant impact within the healthcare industry, she transitioned into oncology and medical business working for several high profile companies specialising in the latest technology. There she was able to continue her passion of oncology and medical research together with business development, commercialisation and advocacy, expanding her network and business relationships locally and internationally.​
Leanne is a graduate of the Australian Institute of Company Directors (GAICD). She is an Honorary Clinical Fellow and a University guest lecturer in both Australia and New Zealand.​
Leanne is a graduate of both Harvard Business School and Harvard Medical School and is an International Keynote Speaker, Writer and Women in Leadership advisor.
Digital & Innovation
Health sector faces new privacy obligations
Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]
MoreNews - Pharmaceuticals
TGA approves new antibiotic but AMR blind spot remains a critical concern
The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]
MoreNews - MedTech & Diagnostics
BCAL Diagnostics rejects merger speculation
ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]
MoreNews - Pharmaceuticals
Australia backs infectious disease innovation as US funding faces more cuts
Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]
More